Investing
The collaboration will provide funding, resources and market access to startups developing healthcare technologies expanding into the United States market from the U.K.
The virtual opioid use disorder company reached profitability in Q4 2024, and expanded its team with the appointments of a chief operating officer and chief financial officer.
The Series C raise comes less than a year after the company secured $50 million in a Series B funding round.
Hone Health completes a $33 million Series A funding round, and Aligned Marketplace raises $11 million in seed funding.
The funds will be used to expand entry into new markets, including Medicaid.
The company will use the funds to scale operations and accelerate its innovation and commercialization initiatives.
The company will use the funds to expand access to its hormonal healthcare platform across the U.S.
The company, in partnership with Microsoft, aims to develop cancer medicines, followed by treatments for autoimmune diseases and rare conditions.
The funds will be used to strengthen the development of its proprietary AI and enhance technology-enabled delivery of clinical trials.
The financing will be used to execute the company's long-term growth initiatives centered on high-margin, scalable recurring revenues across B2B and pharma channels.